Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Taha

Showing results (21-30 of 177) with videos related to

Pageof 18
Sort By:
Current Computer-Aided Drug Design|June 12, 2020
Elaboration of Novel TTK1 Inhibitory Leads via QSAR-Guided Selection of Crystallographic Pharmacophores Followed By In Vitro AssayMahmoud A Al-Sha'er, Mutasem O Taha
Heliyon|June 14, 2019
Degradability of chitosan micro/nanoparticles for pulmonary drug deliveryNazrul Islam, Isra Dmour, Mutasem O Taha
British Dental Journal|April 22, 2011
Reforming surroundingsO Taha, I Al-Hadad, C Gallagher
Journal of Molecular Graphics & Modelling|February 20, 2018
Ligand-based modeling of Akt3 lead to potent dual Akt1/Akt3 inhibitorMahmoud A Al-Sha'er, Mutasem O Taha
Journal of Chemical Information and Modeling|April 4, 2009
Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitorsAreej M Abu Hammad, Mutasem O Taha
Journal of Computer-Aided Molecular Design|December 17, 2013
Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitorsSawsan Abuhamdah, Maha Habash, Mutasem O Taha
Journal of Molecular Modeling|June 19, 2012
Application of docking-based comparative intermolecular contacts analysis to validate Hsp90α docking studies and subsequent in silico screening for inhibitorsMahmoud A Al-Sha'er, Mutasem O Taha
European Journal of Medicinal Chemistry|July 20, 2010
Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassayMahmoud A Al-Sha'er, Mutasem O Taha
Journal of Chemical Information and Modeling|September 14, 2010
Elaborate ligand-based modeling reveals new nanomolar heat shock protein 90α inhibitorsMahmoud A Al-Sha'er, Mutasem O Taha
Journal of Molecular Graphics & Modelling|March 8, 2011
Discovery of new renin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluationAfaf H Al-Nadaf, Mutasem O Taha
Pageof 18

Showing results (21-30 of 177) with videos related to

Sort By:
Pageof 18
Current Computer-Aided Drug Design|June 12, 2020
Elaboration of Novel TTK1 Inhibitory Leads via QSAR-Guided Selection of Crystallographic Pharmacophores Followed By In Vitro AssayMahmoud A Al-Sha'er, Mutasem O Taha
Heliyon|June 14, 2019
Degradability of chitosan micro/nanoparticles for pulmonary drug deliveryNazrul Islam, Isra Dmour, Mutasem O Taha
British Dental Journal|April 22, 2011
Reforming surroundingsO Taha, I Al-Hadad, C Gallagher
Journal of Molecular Graphics & Modelling|February 20, 2018
Ligand-based modeling of Akt3 lead to potent dual Akt1/Akt3 inhibitorMahmoud A Al-Sha'er, Mutasem O Taha
Journal of Chemical Information and Modeling|April 4, 2009
Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitorsAreej M Abu Hammad, Mutasem O Taha
Journal of Computer-Aided Molecular Design|December 17, 2013
Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitorsSawsan Abuhamdah, Maha Habash, Mutasem O Taha
Journal of Molecular Modeling|June 19, 2012
Application of docking-based comparative intermolecular contacts analysis to validate Hsp90α docking studies and subsequent in silico screening for inhibitorsMahmoud A Al-Sha'er, Mutasem O Taha
European Journal of Medicinal Chemistry|July 20, 2010
Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassayMahmoud A Al-Sha'er, Mutasem O Taha
Journal of Chemical Information and Modeling|September 14, 2010
Elaborate ligand-based modeling reveals new nanomolar heat shock protein 90α inhibitorsMahmoud A Al-Sha'er, Mutasem O Taha
Journal of Molecular Graphics & Modelling|March 8, 2011
Discovery of new renin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluationAfaf H Al-Nadaf, Mutasem O Taha
Pageof 18